content top

The Incidence and Causes of Abrupt Visual Loss During Anti-vascular Endothelial Growth Factor (VEGF) Treatment for Type 3 Neovascularization

SCIENTIFIC POSTER The Incidence and Causes of Abrupt Visual Loss by Jae Hui Kim, Young Suk Chang, Jong Woo Kim, ChulGu Kim, Dong Won Lee, South Korea ABSTRACT Purpose: To investigate the incidence and causes of abrupt visual loss during anti-vascular endothelial growth factor (VEGF) treatment for type 3 neovascularization. Methods: This retrospective study included 137 eyes that were newly diagnosed with type 3 neovascularization. All eyes...

Read More

Response of Pigment Epithelial Detachment to Anti-VEGF Treatment in AMD

SCIENTIFIC POSTER 2016_Response of Pigment Epithelial Detachment to Anti-VEGF Treatment in AMD Han Joo Cho Objective: To evaluate the therapeutic response of pigment epithelial detachment (PED) to anti-vascular endothelial growth factor (VEGF) treatment in neovascular age-related macular degeneration (nAMD), and identify predictive factors for PED resolution after treatment. Methods: A total of 202 treatment-naive nAMD eyes presenting PED...

Read More

Evaluation of Subfoveal Choroidal and Central Retinal Thickness in Normal Eyes

Ohjae Kim_SCIENTIFIC POSTER 2015_1 Purpose: To determine subfoveal choroidal thickness and central retinal thickness using optical coherence tomography (OCT) and to evaluate association between both thickness and age, gender and axial length. Methods: Spectral domain OCT images (Bioptigen, Bioptigen, inc., Durham, NC) were obtained in 151 eyes of 151 healthy volunteers without retinal diseases. The IOL master (Carl Zeiss Meditech) was used...

Read More

Six Months Results of Aflibercept versus Ranibizumab for Treatment of Wet-AMD

Oh Jae Kim_SCIENTIFIC POSTER 2015 Purpose: To compare the six-month clinical results of ranibizumab with aflibercept for the treatment of wet age-related macular degeneration (wet-AMD). Methods: Medical records of 44 eyes of 44 patients who underwent intravitreal ranibizumab (0.5mg / 0.05ml) or aflibercept (2.0mg / 0.05ml) injection for wet-AMD with more than 6 months of follow-up were reviewed retrospectively. All patients were treated...

Read More

Characteristics and Surgical Outcome of MH Developed After RRD Repair

SCIENTIFIC POSTER_Joo Yeon Kim Purpose: To report the characteristics and surgical outcomes of macular holes (MHs) that develop after rhegmatogenous retinal detachment (RD) repair. Methods: A retrospective chart review was performed in patients who developed a full-thickness macular hole after RD repair between May 2010 to July 2013. The eyes underwent MH repair with pars plana vitrectomy, internal limiting membrane peeling and gas...

Read More
content top